It’s basically lore now.
Beginning in late 2023, Apple and the medical technology company Masimo had a patent dispute regarding the use of the blood oxygen feature used in the Series 9 and Ultra 2.
There was an International Trade Commission (ITC) ruling and, well, Masimo won.
This resulted in Apple being forced to sell modified versions of the Series 9 and Ultra 2 — and subsequently the Series 10 — with the blood oxygen feature disabled since early 2024. If you already owned a Series 9 or Ultra 2, Apple rolled out a firmware update that also disabled the feature.
Well, as of today, Apple has seemingly found a workaround and is now reintroducing blood oxygen monitoring to previously disabled Apple Watch models.
A banned feature, returned

In a news post, Apple has stated that it’s rolling out a firmware update that will enable blood oxygen monitoring on the Series 9, Series 10 and Ultra 2. But it’s a little different than before.